Discontinued — last reported Q1 '18
Iron Mountain Allowance for Doubtful Accounts Receivable (Current) increased by 1.4% to $109.36M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $90.61M to $109.36M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 13.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.98M | $60.21M | $62.01M | $61.17M | $55.72M | $52.70M | $54.14M | $61.04M | $65.22M | $71.15M | $74.76M | $77.41M | $78.51M | $84.19M | $86.71M | $90.61M | $101.90M | $106.59M | $107.84M | $109.36M |
| QoQ Change | — | +5.7% | +3.0% | -1.4% | -8.9% | -5.4% | +2.7% | +12.7% | +6.8% | +9.1% | +5.1% | +3.5% | +1.4% | +7.2% | +3.0% | +4.5% | +12.5% | +4.6% | +1.2% | +1.4% |
| YoY Change | — | — | — | — | -2.2% | -12.5% | -12.7% | -0.2% | +17.1% | +35.0% | +38.1% | +26.8% | +20.4% | +18.3% | +16.0% | +17.0% | +29.8% | +26.6% | +24.4% | +20.7% |